
Spravato® (esketamine) is an FDA-approved treatment for adults with treatment-resistant depression and for those experiencing depressive symptoms with suicidal thoughts or behaviors. It offers a different approach than traditional antidepressants and may provide relief when other treatments have not been effective.
Spravato® is a nasal spray administered in a monitored clinical setting. Unlike traditional medications that primarily affect serotonin, Spravato® targets the glutamate system—helping to restore connections in the brain that impact mood, cognition, and emotional regulation.
Spravato® may be appropriate for individuals who:
A comprehensive evaluation is required to determine if Spravato® is appropriate for you.
Treatment typically begins with twice-weekly sessions, followed by a gradual reduction in frequency based on your response.
Spravato® is only available through a certified program due to potential side effects, including:
Your safety is our priority. Vital signs and response are closely monitored throughout each session.
Coverage for Spravato® varies by insurance plan. Our office will assist with benefits verification and prior authorization when applicable. Self-pay options may be available.
We provide a supportive, calm, and private environment for treatment. Each patient receives individualized care, including ongoing evaluation, medication management, and coordination with your broader treatment team when appropriate.
If you’re struggling with depression and have not found relief, Spravato® may be an option worth exploring.
📞 Call: 603-718-3939
15 Constitution Drive, Bedford, NH, USA
Phone: 603-718-3939 Fax: 603-583-3939 Email: northernlightspsychiatry@gmail.com
Mon | 01:00 pm – 06:00 pm | |
Tue | 09:00 am – 06:00 pm | |
Wed | 09:00 am – 06:00 pm | |
Thu | 09:00 am – 06:00 pm | |
Fri | 09:00 am – 06:00 pm | |
Sat | By Appointment | |
Sun | By Appointment |